Pharmaxis completes clinical trial with the antifibrotic agent, PXS25
9th
Feb 10
Release Date: 09/02/2010 12:00am
Pharmaxis today announced it had completed the first Phase I clinical trial in healthy volunteers with its new drug candidate, PXS25.
Categories: News and Media